Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Newey, P. J
Right arrow Articles by Jamieson, A.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pituitary failure, metformin and hypoglycaemia in type 2 diabetes

Paul J Newey

John Radcliffe Hospital, Headley Way, Oxford, Headington, OX3 9DU, UK

Youssif Abousleiman

Queen Margaret Hospital, Dunfermline, Fife, KY12 0SU, Scotland

Andrew Jamieson

Hairmyres Hospital, Eaglesham Road, East Kilbride, Glasgow, G75 8RG, Scotland, drandrew.jamieson{at}btopenworld.com

References

  • UK Prospective Diabetes Study (UKPDS) Group. Effects of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jones GC, Macklin JP, Alexander WD Contraindications to the use of metformin. BMJ 2003;326:4-5.[Free Full Text]
  • Tattersall RB Frequency, causes and treatment of hypoglycaemia. In: Frier BM and Fisher BM (eds), Hypoglycaemia in clinical diabetes. 1999. Chichester: Wiley and Sons: pp 55-87.
  • Salpeter S., Greyber E., Pasternak G., Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). Cochrane Database Syst Rev 2003;(2):CD002967.
  • Howlett HCS, Bailey CJ A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 1999;20:489-503.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Seltzer HS Drug-induced hypoglycaemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989;18(1):163-83.[Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 2, 128-130 (2004)
DOI: 10.1177/14746514040040021201


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Newey, P. J
Right arrow Articles by Jamieson, A.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?